Follow
Precision oncology biomarkers testing
Biomarker testing for oncology aims to identify genes, proteins, or tumor markers that are specific to the cancer. Understanding the biomarkers present in a certain cancer helps optimize therapeutic regimens and inform personalized medicine strategies.
What's Popular in Precision oncology biomarkers testing
-
APR 27, 2023Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth ...Written By: Carmen LeitchAUG 08, 2022Immunology
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass ...Sponsored By: Slingshot Biosciences, Inc.MAR 04, 2021Clinical & Molecular DX
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining ...Written By: Tara FernandesNOV 09, 2020Genetics & Genomics
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...Written By: Carmen LeitchNOV 03, 2020Genetics & Genomics
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...Written By: Carmen Leitch
APR 27, 2023
Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth
...
Written By:
Carmen Leitch
AUG 08, 2022
Immunology
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass
...
Sponsored By:
Slingshot Biosciences, Inc.
MAR 04, 2021
Clinical & Molecular DX
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining
...
Written By:
Tara Fernandes
NOV 09, 2020
Genetics & Genomics
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool
...
Written By:
Carmen Leitch
NOV 03, 2020
Genetics & Genomics
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr
...
Written By:
Carmen Leitch
JAN 30, 2019
Cancer
Doctors from the Memorial Sloan Kettering Cancer Center in New York recently published a paper in Nature detai
...
Written By:
Amy Loriaux
AUG 16, 2018
Clinical & Molecular DX
Researchers have developed a proof-of-concept technique that allows them to detect brain tumor biomarkers with a simple
...
Written By:
Futurity (futurity.org)
AUG 10, 2018
Immunology
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors
...
Written By:
Caitlin Williams
JUN 05, 2018
Cancer
Phase III clinical trial research shows evidence that early breast cancer patients with common breast cancer type do not
...
Written By:
Mauri Brueggeman
-
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...OCT 10, 2023 | 10:00 AMC.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...MAR 30, 2023 | 12:05 PMC.E. CREDITS
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...Speaker: Dr. Chi-Cheng Huang, PhDPresented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
MAR 30, 2023 | 12:05 PM
C.E. CREDITS
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
AUG 24, 2022 | 8:00 AM
Date: August 24, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Next Generation Sequencing (NGS) has evolved rapidly since the first sequencing platforms were commercially released ne...
OCT 07, 2021 | 12:00 PM
Across oncology applications, from research to molecular testing and pharmaceutical development, the ability to identify potentially actionable genetic alterations and exploit the molecular...
Speaker:
Beate Litzenburger, Ph.D.
, Sheryl Elkin, PhD
JUN 10, 2021 | 9:05 AM
High volume clinical MS proteomic evaluation of plasma samples enriched for exosomes offering a real-time and non-invasive perspective of changing maternal and fetal tissues....
Speaker:
Kevin Rosenblatt, MD, PhD
Presented at: Shaping the Future of LC-MS in Life Science Together
APR 29, 2021 | 1:35 PM
In examining the potential adoption of the Oncomine Precision Assay, University of Texas Health had several criteria to consider, including the need for highly accurate detection of small sa...
Speaker:
Leomar Ballester, MD, PhD
Presented at: OncomineWorld 2022: A Virtual NGS Education Meeting
